Wolverine Asset Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Wolverine Asset Management’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-39,326	Closed	-$1.51M	–	2077
2023 Q2	$1.51M	Buy	+39,326	New	+$1.01M	0.02%	571

Wolverine Asset Management's KDNY Position: Q3 2023 in Review

Wolverine Asset Management sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 39,326 shares — an estimated $1.51M sold.

Wolverine Asset Management first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $1.51M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Wolverine Asset Management reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Wolverine Asset Management sold 39,326 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.51M.
Wolverine Asset Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Wolverine Asset Management's Chinook Therapeutics, Inc. Common Stock position peaked at $1.51M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Wolverine Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.